Transcripts were reconstructed using StringTie (v2.1.0) based on HISAT2 (v2.1.0) alignment, and gene expression levels were calculated using RSEM (v1.2.19) and quantified as FPKM (Fragments Per Kilobase of transcript per Million mapped reads)
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
Patients must be clearly informed of the risks associated with nonFDA-approved products, including potential contamination, inaccurate dosing, variable bioactivity, and the presence of impurities that may provoke adverse or unpredictable effects
The mechanistic case for integration is compelling
The standard BPC-157 dosage is 250-500 mcg injected subcutaneously once or twice daily for 4-8 weeks, adjusted for injury type, body weight, and reconstitution concentration
Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer: Is There a Role for Selective Surgery